Reduced Circulating Adiponectin Levels Are Associated with the Metabolic Syndrome Independently of Obesity, Lipid Indices and Serum Insulin Levels: a Cross-sectional Study

Overview

Journal Lipids Health Dis

Publisher Biomed Central

Specialties Biochemistry
Endocrinology

Date 2016 Aug 29

PMID 27567677

Citations 14

Authors

Agathi Ntzouvani

Elisabeth Fragopoulou

Demosthenes Panagiotakos

Christos Pitsavos

Smaragdi Antonopoulou

Affiliations

Soon will be listed here.

Abstract

Background: Given the increasing rate of overweight and the burden of metabolic syndrome (MetS) on cardiovascular disease development, better understanding of the syndrome is of great importance. Therefore, the objectives were to examine whether interleukin-6 (IL-6) and adiponectin are associated with MetS, and whether this association is mediated by components of the MetS.

Methods: During 2011-2012, 284 individuals (159 men, 53 ± 9 years, 125 women 52 ± 9 years) without cardiovascular disease, type 1 diabetes mellitus, high-grade inflammatory disease, living in the greater Athens area, Greece, participated in clinical examination. Adiponectin and IL-6 were measured in fasting plasma samples. MetS was defined according to the International Diabetes Federation (IDF) and the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) criteria.

Results: MetS was present in 37 % (IDF) and 33 % (AHA/NHLBI) of the study population (P < 0.001). Adiponectin was inversely associated with MetS (odds ratio, 95 % confidence interval: 0.829, 0.762- 0.902 for MetS-IDF, and 0.840, 0.772- 0.914 for MetS-AHA/NHLBI). Body mass index (BMI), waist circumference, high density lipoprotein (HDL)-cholesterol, triglyceride and insulin concentration mediated the association between adiponectin and MetS-IDF (z-test, standard error, P-value: 2.898, 0.012, 0.004, for BMI; 2.732, 0.012, 0.006 for waist circumference; 2.388, 0.011, 0.017 for HDL-cholesterol; 2.163, 0.010, 0.031 for triglyceride; 2.539, 0.010, 0.011 for insulin). Similarly, BMI, waist circumference, HDL-cholesterol and insulin concentration mediated the association between adiponectin and MetS-AHA/NHLBI (z-test, standard error, P-value: 2.633, 0.011, 0.008 for BMI; 2.441, 0.011, 0.015 for waist circumference; 1.980, 0.010, 0.048 for HDL-cholesterol; 2.225, 0.009, 0.026 for insulin). However, adiponectin remained significantly associated with MetS. IL-6 was not significantly associated with MetS.

Conclusion: MetS components, in particular obesity and lipid indices, as well as serum insulin levels, mediate the association between adiponectin and MetS as defined by both the IDF and AHA/NHLBI criteria.

Citing Articles

Peripheral inflammation is linked with emotion and mental health in people with obesity. A "head to toe" observational study.

Amerikanou C, Valsamidou E, Kleftaki S, Gioxari A, Koutoulogenis K, Aroutiounova M Front Endocrinol (Lausanne). 2023; 14:1197648.

PMID: 37529617 PMC: 10390304. DOI: 10.3389/fendo.2023.1197648.

Anti-Obesity and Anti-Inflammatory Synergistic Effects of Green Tea Catechins and Citrus β-Cryptoxanthin Ingestion in Obese Mice.

Nakadate K, Kawakami K, Yamazaki N Int J Mol Sci. 2023; 24(8).

PMID: 37108217 PMC: 10138730. DOI: 10.3390/ijms24087054.

Extra virgin olive oil extract rich in secoiridoids induces an anti-inflammatory profile in peripheral blood mononuclear cells from obese children.

De Santis S, Crupi P, Piacente L, Mestice A, Colabufo N, Amodio L Front Nutr. 2022; 9:1017090.

PMID: 36386923 PMC: 9643887. DOI: 10.3389/fnut.2022.1017090.

The Translation and Commercialisation of Biomarkers for Cardiovascular Disease-A Review.

Saleh S, George J, Kott K, Meikle P, Figtree G Front Cardiovasc Med. 2022; 9:897106.

PMID: 35722087 PMC: 9201254. DOI: 10.3389/fcvm.2022.897106.

Athrixia phylicoides tea infusion (bushman tea) improves adipokine balance, glucose homeostasis and lipid parameters in a diet-induced metabolic syndrome rat model.

Mokwena M, Engwa G, Nkeh-Chungag B, Sewani-Rusike C BMC Complement Med Ther. 2021; 21(1):292.

PMID: 34844584 PMC: 8628465. DOI: 10.1186/s12906-021-03459-z.

References

FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

Gannage-Yared M, Khalife S, Semaan M, Fares F, Jambart S, Halaby G . Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur J Endocrinol. 2006; 155(1):167-76. DOI: 10.1530/eje.1.02175. View

Saito I, Yamagishi K, Chei C, Cui R, Ohira T, Kitamura A . Total and high molecular weight adiponectin levels and risk of cardiovascular disease in individuals with high blood glucose levels. Atherosclerosis. 2013; 229(1):222-7. DOI: 10.1016/j.atherosclerosis.2013.04.014. View

von Frankenberg A, do Nascimento F, Gatelli L, Nedel B, Garcia S, de Oliveira C . Major components of metabolic syndrome and adiponectin levels: a cross-sectional study. Diabetol Metab Syndr. 2014; 6(1):26. PMC: 3941563. DOI: 10.1186/1758-5996-6-26. View

Hoene M, Weigert C . The role of interleukin-6 in insulin resistance, body fat distribution and energy balance. Obes Rev. 2007; 9(1):20-9. DOI: 10.1111/j.1467-789X.2007.00410.x. View

You T, Nicklas B, Ding J, Penninx B, Goodpaster B, Bauer D . The metabolic syndrome is associated with circulating adipokines in older adults across a wide range of adiposity. J Gerontol A Biol Sci Med Sci. 2008; 63(4):414-9. PMC: 10068865. DOI: 10.1093/gerona/63.4.414. View

Nomikos T, Panagiotakos D, Georgousopoulou E, Metaxa V, Chrysohoou C, Skoumas I . Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study. Lipids Health Dis. 2015; 14:108. PMC: 4570524. DOI: 10.1186/s12944-015-0101-7. View

Kim J, Ahn S, Yoon J, Koh S, Yoon J, Yoo B . Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study. Diabetes Care. 2013; 36(6):1547-53. PMC: 3661834. DOI: 10.2337/dc12-0223. View

Maury E, Brichard S . Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2009; 314(1):1-16. DOI: 10.1016/j.mce.2009.07.031. View

10.

Salas-Salvado J, Granada M, Bullo M, Corominas A, Casas P, Foz M . Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome. Metabolism. 2007; 56(11):1486-92. DOI: 10.1016/j.metabol.2007.06.014. View

11.

Maahs D, Ogden L, Snell-Bergeon J, Kinney G, Wadwa R, Hokanson J . Determinants of serum adiponectin in persons with and without type 1 diabetes. Am J Epidemiol. 2007; 166(6):731-40. DOI: 10.1093/aje/kwm125. View

12.

Ridker P . Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003; 107(3):363-9. DOI: 10.1161/01.cir.0000053730.47739.3c. View

13.

Mohamed-Ali V, Goodrick S, Rawesh A, Katz D, Miles J, Yudkin J . Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997; 82(12):4196-200. DOI: 10.1210/jcem.82.12.4450. View

14.

Choi K, Ryu O, Lee K, Kim H, Seo J, Kim S . Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome. Diabetes Res Clin Pract. 2006; 75(2):235-40. DOI: 10.1016/j.diabres.2006.06.019. View

15.

Papathanasiou G, Georgoudis G, Papandreou M, Spyropoulos P, Georgakopoulos D, Kalfakakou V . Reliability measures of the short International Physical Activity Questionnaire (IPAQ) in Greek young adults. Hellenic J Cardiol. 2009; 50(4):283-94. View

16.

Panagiotakos D, Pitsavos C, Chrysohoou C, Skoumas J, Masoura C, Toutouzas P . Effect of exposure to secondhand smoke on markers of inflammation: the ATTICA study. Am J Med. 2004; 116(3):145-50. DOI: 10.1016/j.amjmed.2003.07.019. View

17.

Kizer J, Arnold A, Benkeser D, Ix J, Djousse L, Zieman S . Total and high-molecular-weight adiponectin and risk of incident diabetes in older people. Diabetes Care. 2011; 35(2):415-23. PMC: 3263897. DOI: 10.2337/dc11-1519. View

18.

Nakashima R, Yamane K, Kamei N, Nakanishi S, Kohno N . Low serum levels of total and high-molecular-weight adiponectin predict the development of metabolic syndrome in Japanese-Americans. J Endocrinol Invest. 2010; 34(8):615-9. DOI: 10.3275/7409. View

19.

Marques-Vidal P, Bastardot F, von Kanel R, Paccaud F, Preisig M, Waeber G . Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study). Clin Endocrinol (Oxf). 2012; 78(2):232-41. DOI: 10.1111/j.1365-2265.2012.04384.x. View

20.

Thewissen M, Damoiseaux J, Duijvestijn A, Van Greevenbroek M, van der Kallen C, Feskens E . Abdominal fat mass is associated with adaptive immune activation: the CODAM Study. Obesity (Silver Spring). 2011; 19(8):1690-8. DOI: 10.1038/oby.2010.337. View